The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Nephrotoxic Effects in High-Risk Patients Undergoing Angiography
Abstract
BACKGROUND: The use of iodinated contrast medium can result in nephropathy. Whether iso-osmolar contrast medium is less nephrotoxic than low-osmolar contrast medium in high-risk patients is uncertain. METHODS: We conducted a randomized, double-blind, prospective, multicenter study comparing the nephrotoxic effects of an iso-osmolar, dimeric, nonionic contrast medium, iodixanol, with those of a low-osmolar, nonionic, monomeric contrast medium, iohexol. The study involved 129 patients with diabetes with serum creatinine concentrations of 1.5 to 3.5 mg per deciliter who underwent coronary or aortofemoral angiography. The primary end point was the peak increase from base line in the creatinine concentration during the three days after angiography. Other end points were an increase in the creatinine concentration of 0.5 mg per deciliter or more, an increase of 1.0 mg per deciliter or more, and a change in the creatinine concentration from day 0 to day 7. RESULTS: The creatinine concentration increased significantly less in patients who received iodixanol. From day 0 to day 3, the mean peak increase in creatinine was 0.13 mg per deciliter in the iodixanol group and 0.55 mg per deciliter in the iohexol group (P=0.001; the increase with iodixanol minus the increase with iohexol, -0.42 mg per deciliter [95 percent confidence interval, -0.73 to -0.22]). Two of the 64 patients in the iodixanol group (3 percent) had an increase in the creatinine concentration of 0.5 mg per deciliter or more, as compared with 17 of the 65 patients in the iohexol group (26 percent) (P=0.002; odds ratio for such an increase in the iodixanol group, 0.09 [95 percent confidence interval, 0.02 to 0.41]). No patient receiving iodixanol had an increase of 1.0 mg per deciliter or more, but 10 patients in the iohexol group (15 percent) did. The mean change in the creatinine concentration from day 0 to day 7 was 0.07 mg per deciliter in the iodixanol group and 0.24 mg per deciliter in the iohexol group (P=0.003; value in the iodixanol group minus the value in the iohexol group, -0.17 mg per deciliter [95 percent confidence interval, -0.34 to -0.07]). CONCLUSIONS: Nephropathy induced by contrast medium may be less likely to develop in high-risk patients when iodixanol is used rather than a low-osmolar, nonionic contrast medium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention
Rihal, C. S., Textor, S. C., Grill, D. E., Berger, P. B., Ting, H. H., Best, P. J., Singh, M., Bell, M. R., Barsness, G. W., Mathew, V., et al. (2002) · Circulation · doi:10.1161/01.cir.0000016043.87291.33 · Cited by 1,712
Acute Renal Failure After Coronary Intervention
McCullough, P. A., Wolyn, R., Rocher, L. L., Levin, R. N., & O’Neill, W. W. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00150-2 · Cited by 1,671
The effect of acute renal failure on mortality. A cohort analysis
Levy, E. M. (1996) · JAMA · doi:10.1001/jama.275.19.1489 · Cited by 1,660
Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine
Tepel, M., van der Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., & Zidek, W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430304 · Cited by 1,588
Solomon, R., Werner, C., Mann, D., D'Elia, J., & Silva, P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312104 · Cited by 1,254
Hypoxia of the Renal Medulla — Its Implications for Disease
Brezis, M., & Rosen, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321006 · Cited by 1,222
Parfrey, P. S., Griffiths, S. M., Barrett, B. J., Paul, M. D., Genge, M., Withers, J., Farid, N., & McManamon, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901193200303 · Cited by 1,011
Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial
Rudnick, M. R., Goldfarb, S., Wexler, L., Ludbrook, P. A., Murphy, M. J., Halpern, E. F., Hill, J. A., Winniford, M., Cohen, M. B., VanFossen, D. B., et al. (1995) · Kidney International · doi:10.1038/ki.1995.32 · Cited by 923
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P., Windecker, S., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,199
Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Chaikof, E. L., Dalman, R. L., Eskandari, M. K., Jackson, B. M., Lee, W. A., Mansour, M. A., Mastracci, T. M., Mell, M., Murad, M. H., Nguyen, L. L., et al. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.10.044 · Cited by 2,751
Bellomo, R., Kellum, J. A., & Ronco, C. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61454-2 · Cited by 2,598
Global Vascular Guidelines on the management of chronic limb-threatening ischemia.
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.02.016 · Cited by 2,015
Diabetic nephropathy: diagnosis, prevention, and treatment
Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., & Zelmanovitz, T. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.164 · Cited by 1,839
Global vascular guidelines on the management of chronic limb-threatening ischemia
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.05.006 · Cited by 1,582
2018 ESC/EACTS Guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · EuroIntervention · doi:10.4244/eijy19m01_01 · Cited by 1,259
X-ray-Computed Tomography Contrast Agents
Lusic, H., & Grinstaff, M. W. (2013) · Chemical Reviews · doi:10.1021/cr200358s · Cited by 1,108
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate: A Randomized Controlled Trial
Merten, G. J., Burgess, W. P., Gray, L. V., Holleman, J. H., Roush, T. S., Kowalchuk, G. J., Bersin, R. M., Van Moore, A., Simonton III, C. A., Rittase, R. A., et al. (2004) · JAMA · doi:10.1001/jama.291.19.2328 · Cited by 1,087
Contrast-Induced Acute Kidney Injury
McCullough, P. A., Choi, J. P., Feghali, G. A., Schussler, J. M., Stoler, R. M., Vallabahn, R. C., & Mehta, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.099 · Cited by 1,067
Acute Kidney Injury Associated with Cardiac Surgery
Rosner, M. H., & Okusa, M. D. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240605 · Cited by 1,063
Guidelines on myocardial revascularization
The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.08.019 · Cited by 1,004
2018 ESC/EACTS Guidelines on myocardial revascularization
Sousa-Uva, M., Neumann, F.-J., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy289 · Cited by 989
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury
Palevsky, P. M., Liu, K. D., Brophy, P. D., Chawla, L. S., Parikh, C. R., Thakar, C. V., Tolwani, A. J., Waikar, S. S., & Weisbord, S. D. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.02.349 · Cited by 935
Contrast-induced nephropathy: Definition, epidemiology, and patients at risk
Mehran, R., & Nikolsky, E. (2006) · Kidney International · doi:10.1038/sj.ki.5000368 · Cited by 891
Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines
on behalf of the Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR), Stacul, F., van der Molen, A. J., Reimer, P., Webb, J. A. W., Thomsen, H. S., Morcos, S. K., Almén, T., Aspelin, P., Bellin, M.-F., et al. (2011) · European Radiology · doi:10.1007/s00330-011-2225-0 · Cited by 884
Self-citationContrast-Induced Acute Kidney Injury
McCullough, P. A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.12.035 · Cited by 822
Chaikof, E. L., Brewster, D. C., Dalman, R. L., Makaroun, M. S., Illig, K. A., Sicard, G. A., Timaran, C. H., Upchurch, G. R., & Veith, F. J. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.07.002 · Cited by 732
Preventing Nephropathy Induced by Contrast Medium
Barrett, B. J., & Parfrey, P. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp050801 · Cited by 597
Pathophysiology of contrast medium–induced nephropathy
Persson, P. B., Hansell, P., & Liss, P. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00377.x · Cited by 544
Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification
Bartholomew, B. A., Harjai, K. J., Dukkipati, S., Boura, J. A., Yerkey, M. W., Glazier, S., Grines, C. L., & O'Neill, W. W. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.008 · Cited by 524
Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach
Tepel, M., Aspelin, P., & Lameire, N. (2006) · Circulation · doi:10.1161/circulationaha.105.595090 · Cited by 506
Self-citationRoffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2015) · Kardiologia Polska · doi:10.5603/kp.2015.0243 · Cited by 458
Latchaw, R. E., Alberts, M. J., Lev, M. H., Connors, J. J., Harbaugh, R. E., Higashida, R. T., Hobson, R., Kidwell, C. S., Koroshetz, W. J., Mathews, V., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.192616 · Cited by 452
Epidemiology and Prognostic Implications of Contrast-Induced Nephropathy
McCullough, P. A., Adam, A., Becker, C. R., Davidson, C., Lameire, N., Stacul, F., & Tumlin, J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.019 · Cited by 436
Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy
Kelly, A. M., Dwamena, B., Cronin, P., Bernstein, S. J., & Carlos, R. C. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00007 · Cited by 435
2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0224 · Cited by 418
Atherosclerotic Vascular Disease Conference: Writing Group III: Pathophysiology
Faxon, D. P., Fuster, V., Libby, P., Beckman, J. A., Hiatt, W. R., Thompson, R. W., Topper, J. N., Annex, B. H., Rundback, J. H., Fabunmi, R. P., et al. (2004) · Circulation · doi:10.1161/01.cir.0000128520.37674.ef · Cited by 414
Stone, G. W., McCullough, P. A., Tumlin, J. A., Lepor, N. E., Madyoon, H., Murray, P., Wang, A., Chu, A. A., Schaer, G. L., Stevens, M., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2284 · Cited by 412
Prophylaxis Strategies for Contrast-Induced Nephropathy
Pannu, N., Wiebe, N., Tonelli, M., & Alberta Kidney Disease Network, F. T. (2006) · JAMA · doi:10.1001/jama.295.23.2765 · Cited by 410
WRITING COMMITTEE MEMBERS, Mark, D. B., Berman, D. S., Budoff, M. J., Carr, J. J., Gerber, T. C., Hecht, H. S., Hlatky, M. A., Hodgson, J. M., Lauer, M. S., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d4b618 · Cited by 388
Risks and Complications of Coronary Angiography: A Comprehensive Review
Tavakol, M., Ashraf, S., & Brener, S. J. (2011) · Global Journal of Health Science · doi:10.5539/gjhs.v4n1p65 · Cited by 380
Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies
Goldenberg, I. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040847 · Cited by 375
Side Effects of Radiographic Contrast Media: Pathogenesis, Risk Factors, and Prevention
Andreucci, M., Solomon, R., & Tasanarong, A. (2014) · BioMed Research International · doi:10.1155/2014/741018 · Cited by 354
Solomon, R. J., Natarajan, M. K., Doucet, S., Sharma, S. K., Staniloae, C. S., Katholi, R. E., Gelormini, J. L., Labinaz, M., Moreyra, A. E., & the Investigators of the CARE Study (2007) · Circulation · doi:10.1161/circulationaha.106.671644 · Cited by 346
Alonso, A., Lau, J., Jaber, B. L., Weintraub, A., & Sarnak, M. J. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.09.009 · Cited by 345
A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study
Baker, C. S. R., Wragg, A., Kumar, S., De Palma, R., Baker, L. R. I., & Knight, C. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00487-x · Cited by 340
2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m09_01 · Cited by 328
Heinrich, M. C., Häberle, L., Müller, V., Bautz, W., & Uder, M. (2009) · Radiology · doi:10.1148/radiol.2501080833 · Cited by 319
Spargias, K., Alexopoulos, E., Kyrzopoulos, S., Iacovis, P., Greenwood, D. C., Manginas, A., Voudris, V., Pavlides, G., Buller, C. E., Kremastinos, D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000146396.19081.73 · Cited by 317
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2024) · European Heart Journal: Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad107 · Cited by 314
Drug-induced acute kidney injury
Schetz, M., Dasta, J., Goldstein, S., & Golper, T. (2005) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000184300.68383.95 · Cited by 313
Dickenmann, M., Oettl, T., & Mihatsch, M. J. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.10.044 · Cited by 311
Grant, K. L., Flohr, T. G., Krauss, B., Sedlmair, M., Thomas, C., & Schmidt, B. (2014) · Investigative Radiology · doi:10.1097/rli.0000000000000060 · Cited by 307
Jo, S.-H., Youn, T.-J., Koo, B.-K., Park, J.-S., Kang, H.-J., Cho, Y.-S., Chung, W.-Y., Joo, G.-W., Chae, I.-H., Choi, D.-J., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.047 · Cited by 288
Systematic review of the impact of N-acetylcysteine on contrast nephropathy
Pannu, N., Manns, B., Lee, H., & Tonelli, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00516.x · Cited by 284
Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies
Azzalini, L., Spagnoli, V., & Ly, H. Q. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.05.013 · Cited by 262
The importance of residual renal function in dialysis patients
Wang, A. Y.-M., & Lai, K.-N. (2006) · Kidney International · doi:10.1038/sj.ki.5000382 · Cited by 257
Kamat, A. M., Flaig, T. W., Grossman, H. B., Konety, B., Lamm, D., O'Donnell, M. A., Uchio, E., Efstathiou, J. A., & Taylor, J. A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.58 · Cited by 252
Pharmacologic Treatment of Acute Kidney Injury: Why Drugs Haven’t Worked and What Is on the Horizon
Jo, S. K., Rosner, M. H., & Okusa, M. D. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03280906 · Cited by 252
Lei, R., Zhao, F., Tang, C.-Y., Luo, M., Yang, S.-K., Cheng, W., Li, X.-W., & Duan, S.-B. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488827 · Cited by 67
Metadata
- Authors
- Aspelin, P., Aubry, P., Fransson, S.-G., Strasser, R., Willenbrock, R., & Berg, K. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-02-06
- Volume
- 348
- Issue
- 6
- Pages
- 491-499
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2021677780
- Cited by
- 1,136
- References
- 17
- FWCI
- 58.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.